We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PEN market cap is 7.43B. The company's latest EPS is USD 2.3415 and P/E is 79.89.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 261.5M | 270.95M | 284.68M | 278.66M | 299.4M |
Operating Income | 17.89M | 12.63M | 35.03M | 12.1M | -80.96M |
Net Income | 18.96M | 9.21M | 54.22M | 11M | -60.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 547.41M | 560.41M | 747.59M | 847.13M | 1.06B |
Operating Income | 47.51M | -38.94M | -7.5M | 6.08M | 73.55M |
Net Income | 48.46M | -15.7M | 5.28M | -2M | 90.95M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.43B | 1.47B | 1.56B | 1.58B | 1.53B |
Total Liabilities | 365.99M | 364.24M | 377.36M | 376.31M | 373.33M |
Total Equity | 1.07B | 1.1B | 1.18B | 1.2B | 1.16B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 665.9M | 822.98M | 1.24B | 1.37B | 1.56B |
Total Liabilities | 180.29M | 185.2M | 290.32M | 372.03M | 377.36M |
Total Equity | 485.61M | 637.79M | 953.93M | 998.86M | 1.18B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 30.23M | 61.07M | 97.33M | 38.3M | 60.91M |
Investing | 4.04M | -40.36M | -16.08M | 18.38M | 52.86M |
Financing | 10.07M | 10.28M | 16.2M | -794k | 7.48M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 26.65M | -33.24M | 9.5M | -55.66M | 97.33M |
Investing | -12.71M | -104.15M | -21.74M | 54.79M | -16.08M |
Financing | -8.96M | 134.92M | 836k | 11.62M | 16.2M |
Market Cap | 7.43B |
Price to Earnings Ratio | 79.89 |
Price to Sales Ratio | 6.86 |
Price to Cash Ratio | 43.38 |
Price to Book Ratio | 6.16 |
Dividend Yield | - |
Shares Outstanding | 38.84M |
Average Volume (1 week) | 425.94k |
Average Volume (1 Month) | 420.57k |
52 Week Change | -28.04% |
52 Week High | 277.34 |
52 Week Low | 148.00 |
Spread (Intraday) | 1.27 (0.66%) |
Company Name | Penumbra Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://www.penumbrainc.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions